vTv Therapeutics (VTVT) Research & Development (2016 - 2025)
Historic Research & Development for vTv Therapeutics (VTVT) over the last 12 years, with Q3 2025 value amounting to $7.0 million.
- vTv Therapeutics' Research & Development rose 11774.19% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.2 million, marking a year-over-year increase of 4137.12%. This contributed to the annual value of $11.5 million for FY2024, which is 1507.17% down from last year.
- vTv Therapeutics' Research & Development amounted to $7.0 million in Q3 2025, which was up 11774.19% from $4.1 million recorded in Q2 2025.
- In the past 5 years, vTv Therapeutics' Research & Development registered a high of $7.0 million during Q3 2025, and its lowest value of $2.1 million during Q4 2023.
- Moreover, its 5-year median value for Research & Development was $3.1 million (2021), whereas its average is $3.4 million.
- In the last 5 years, vTv Therapeutics' Research & Development crashed by 4606.46% in 2023 and then surged by 11774.19% in 2025.
- vTv Therapeutics' Research & Development (Quarter) stood at $5.4 million in 2021, then fell by 26.62% to $4.0 million in 2022, then plummeted by 46.06% to $2.1 million in 2023, then rose by 4.49% to $2.2 million in 2024, then surged by 214.23% to $7.0 million in 2025.
- Its last three reported values are $7.0 million in Q3 2025, $4.1 million for Q2 2025, and $2.8 million during Q1 2025.